Brief discussion: Medicolegal aspects of consent and checklists for common cosmetic procedures

Cosmetic Dermatology

Volumn 20, Issue 5, 2007, Pages 291-294

  Tonkovic Capin, Marija ^a   Riddle, Christy C ^a   Schweiger, Eric S ^a   Aires, Daniel J ^a,b   Mason, Stephen H ^a   Tonkovic Capin, Viseslav ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b Stiefel Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; FILLER;

CHECKLIST; DERMATOLOGICAL PROCEDURES; ESTHETIC SURGERY; ESTHETICS; HEALTH CARE QUALITY; INFORMED CONSENT; INVASIVE PROCEDURE; MEDICAL EXAMINATION; MEDICOLEGAL ASPECT; REVIEW; STANDARDIZATION; SURGICAL TECHNIQUE;

EID: 34347353061     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Jones B. Legal aspects of consent. BJU Int. 2000;86:275-279.
2. Lynn v Hugo, 96 NY2d 306 (NY 2001).
3. Wilson JB, Arpey CJ. Body dysmorphic disorder: suggestions for detection and treatment in a surgical dermatology practice. Dermatol Surg. 2004;30:1391-1399.
4. Rosen LL. Body dysmorphic disorder. Plast Surg Prod. September 2005. Available at: http://www.plasticsurgeryproductsonline.com/article.php?s= PSP/2005/09&p=13. Accessed March 16, 2007.
5. Makdessian AS, Ellis DA, Irish JC. Informed consent in facial plastic surgery: effectiveness of a simple educational intervention. Arch Facial Plast Surg. 2004;6:26-30.
6. Armstrong AP, Cole AA, Page RE. Informed consent: are we doing enough? Br J Plast Surg. 1997;50:637-640.
7. Ellis DA, Hopkin JM, Leitch AG, et al. "Doctors' orders": controlled trial of supplementary, written information for patients. Br Med J. 1979;1:456-501.
8. Botox [package insert]. Irvine, Calif: Allergan, Inc; 2005.
9. New device approval: Restylane™ Injectable Gel - P020023. US Food and Drug Administration Center for Devices and Radiological Health Web site. Available at: http://www.fda.gov/cdrh/MDA/DOCS/p020023.html. Accessed March 16, 2007.
10. New device approval: Radiesse - P050037. US Food and Drug Administration Center for Devices and Radiological Health Web site. Available at: http://www.fda.gov/cdrh/mda/docs/p050037.html. Accessed March 16, 2007.
11. Goldberg DJ. Legal ramifications of off-label filler use. Dermatol Ther. 2006;19:189-193.
12. Putting a new face on the future of aesthetic medicine. Restylane Web site. Available at: http://www.restylaneusa.com/hcarepros_webcasts.asp. Accessed March 16, 2007.
13. Techniques. Radiesse Website. Available at: http://www.radiesse.com/ worldwide/doctor-regulatory.html. Accessed March 16, 2007.
14. Monheit GD. Chemical peels. Skin Therapy Lett. 2004;9:6-11.
15. Cox SE, Butterwick KJ. Chemical peels. In: Robinson JK, Hanke CW, Sengelmann RD, et al, eds. Surgery of the Skin: Procedural Dermatology. 1st ed. Philadelphia, Pa: Elsevier; 2005: 463-482.
16. Carruthers A, Carruthers J. Use of botulinum toxin type A in facial rejuvenation. In: Robinson JK, Hanke CW, Sengelmann RD, et al, eds. Surgery of the Skin: Procedural Dermatology. 1st ed. Philadelphia, Pa: Elsevier; 2005:501-512.